| Structure |
Chemical Name |
CAS |
MF |
 |
グアニジン |
113-00-8 |
CH5N3 |
 |
Vecuronium Bromide ImpurityACDEFGHJKL |
|
|
 |
Ropivacaine Impurity 50 |
|
|
![2-(5-Acetyl-2-ethoxyphenyl)-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazin-4(1H)-one](/CAS/20210111/GIF/358390-43-9.gif) |
2-(5-Acetyl-2-ethoxyphenyl)-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazin-4(1H)-one |
358390-43-9 |
C19H22N4O3 |
 |
Vortioxetine Impurity 4 |
1293489-77-6 |
C18H22N2S |
 |
Brexpiprazole Impurity 2 |
2094559-58-5 |
C38H40N4O4S |
 |
DESTHIAZOLYLMETHYL RITONAVIR |
256328-82-2 |
C33H43N5O4S |
 |
2-イソプロピル-6-プロピルフェノール |
74663-48-2 |
C12H18O |
 |
Ceritinib IMpurity |
|
|
 |
Daclatasvir Impurity |
1417333-83-5 |
C40H50N8O6 |
 |
Apixaban Impurities 15 Complete Set |
|
|
 |
3'-Desethoxy Drotaverine Hydrochloride |
85475-87-2 |
C22H28ClNO4 |
 |
Tofacitinib Impurity K |
|
|
 |
Nilotinib Impurity 1 |
641571-05-3 |
C28H22F3N7O |
 |
(S)-3-Dimethylamino-3-phenylpropanol |
82769-75-3 |
C11H17NO |
![N-Benzoyl-N-[2-(phenyl)ethyl]-N-carbamic Acid R-Quinuclidinol Ester Succinic Acid Salt](/CAS/20140608/GIF/CB12701784.gif) |
N-Benzoyl-N-[2-(phenyl)ethyl]-N-carbamic Acid R-Quinuclidinol Ester Succinic Acid Salt |
1798817-92-1 |
C27H32N2O7 |
 |
2-amino-9-((1R,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one |
1367369-81-0 |
C12H15N5O3 |
 |
N-Methyl-N,N-bis(2-pyridylethyl)amine |
5452-87-9 |
C15H19N3 |
![2,4-ジヒドロ-4-[4-[4-(4-メトキシフェニル)-1-ピペラジニル]フェニル]-2-(1-メチルプロピル)-3H-1,2,4-トリアゾール-3-オン](/CAS/GIF/252964-68-4.gif) |
2,4-ジヒドロ-4-[4-[4-(4-メトキシフェニル)-1-ピペラジニル]フェニル]-2-(1-メチルプロピル)-3H-1,2,4-トリアゾール-3-オン |
252964-68-4 |
C23H29N5O2 |
 |
Ampicillin EP Impurity P |
|
|
 |
(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(M-tolyl)propan-1-aMine |
253337-60-9 |
C22H25N |
 |
Tegafur Impurity BCB |
|
|
![4-(benzo[b]thiophen-4-yl)-1,1-bis(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)piperazin-1-ium chloride](/CAS/20211123/GIF/2454317-16-7.gif) |
4-(benzo[b]thiophen-4-yl)-1,1-bis(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)piperazin-1-ium chloride |
2454317-16-7 |
C38H41N4O4S |
 |
4-(difluoromethoxy)-N1-((3,4-dimethoxypyridin-2-yl)methyl)benzene-1,2-diamine |
2641896-99-1 |
C15H17F2N3O3 |
 |
1-((2R,3R)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one |
2243786-01-6 |
C30H35N5O3 |
 |
Cefoxitin iMpurity F (S-Methoxy cefoxitin) |
|
|
 |
Amido Ethyl Meloxicam (Meloxicam Impurity) |
881399-30-0 |
C16H17N3O4S2 |
 |
Benzoic acid, 4-(3-hydroxy-1-propenyl)-, ethyl ester |
89113-43-9 |
C12H14O3 |
 |
Clopidogrel Impurity C |
1346605-15-9 |
C16H18ClNO2S |
 |
Sitagliptin Impurity 82 |
|
|
 |
(2R,3R)-3-アミノ-2-ヒドロキシ-3-フェニルプロパン酸メチル |
157722-44-6 |
C10H13NO3 |
 |
Aztreonam Open-Ring Desulfurization Impurity |
|
|
 |
4-(2-ヒドロキシ-3-イソプロピルアミノプロポキシ)安息香酸 |
72570-70-8 |
C13H19NO4 |
![2-bromo-3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile](/) |
2-bromo-3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile |
|
|
 |
Acotiamide Impurity |
198470-83-6 |
C20H21N2NaO4S |
 |
trans-ゼアチン-9-β-D-グルコシド |
56329-06-7 |
C16H23N5O6 |
 |
Erlotinib Impurity 28 |
|
|
 |
BIS VALACYCLOVIR (〜90%) |
1356019-51-6 |
C27H40N12O8 |
 |
Avanafil IMpurity 8 (R-Avanafil) |
|
|
 |
fenofibrate iMpurity |
|
|
 |
EthanediaMide iMpurity k |
2803419-58-9 |
C2H4N2O2 |
 |
10-デアセチル-10-オキソバッカチンV |
151636-94-1 |
C29H34O10 |
 |
Levofloxacin Hydroxy Acid |
1036016-10-0 |
C18H21F2N3O4 |
 |
Cabozantinib impurity 1 |
748707-58-6 |
C17H16N2O3 |
 |
Lenacapavir impurity |
2939763-16-1 |
C40H34ClF10N7O5S2 |
 |
Penicillin impurity E |
|
|
 |
Afatinib impurity 84 |
|
|
 |
4-Hydroxy Omeprazole |
301669-82-9 |
C16H17N3O3S |
 |
Latamoxef impurity B |
|
|
 |
Dabigatran Impurity 5 |
|
|
 |
O-descarbonyl O-Acetyl Linezolid |
333753-71-2 |
C15H22FN3O3 |
 |
9-Nitrominocycline |
149934-16-7 |
C23H26N4O9 |
 |
Lasmiditan Impurity 3 |
2941086-99-1 |
|
 |
5,6-ジメトキシ-3-ヒドロキシインダン-1-オン |
148517-82-2 |
C11H12O4 |
 |
Linagliptin Impurity S |
668273-74-3 |
C30H36N8O4 |
![SALMETEROL RELATED COMPOUND A (4-[1-ヒドロキシ-2-(4-フェニルブチルアミノ)エチル]-2-(ヒドロキシメチル)フェノール)](/CAS/20180703/GIF/1798014-51-3.gif) |
SALMETEROL RELATED COMPOUND A (4-[1-ヒドロキシ-2-(4-フェニルブチルアミノ)エチル]-2-(ヒドロキシメチル)フェノール) |
1798014-51-3 |
C19H25NO3 |
 |
Oseltamivir Impurity 109 |
|
|
 |
Apixaban Impurity 29 |
|
|
 |
sofosBuvir Impurity 34 |
|
|
 |
Rivaroxaban degradation impurity 2 |
|
|
 |
Octyl Orlistat |
1243011-56-4 |
C31H57NO5 |
 |
1-(5,6,7,8-tetrahydronaphthalen-1-yl)ethan-1-amine hydrochloride |
154377-56-7 |
C12H17N |
 |
Rivaroxaban Impurity 36 |
1770812-39-9 |
C19H17Cl2N3O5S |
![9-Azabicyclo[3.3.1]Nonane-9-Acetic Acid, 3-(Ethoxycarbonyl)-7-Oxo-, Ethyl Ester](/CAS/GIF/115956-03-1.gif) |
9-Azabicyclo[3.3.1]Nonane-9-Acetic Acid, 3-(Ethoxycarbonyl)-7-Oxo-, Ethyl Ester |
115956-03-1 |
C15H23NO5 |
 |
Nifedipine Impurity 3 |
|
C19H22N2O6 |
 |
4-Desmethoxy-4-chloro Omeprazole Sulfide |
220757-74-4 |
C16H16ClN3OS |
 |
(8S,11S,Z)-5-(2-Aminothiazol-4-yl)-11-(3-guanidinopropyl)-2,2-dimethyl-6,9-dioxo-8-((S)-1-(sulfoamino)ethyl)-3-oxa-4,7,10-triazadodec-4-ene-1,12-dioic Acid |
|
C19H31N9O10S2 |
 |
Telmisartan EP Impurity B Complete Set |
|
|
 |
Rivaroxaban Impurity 22 |
1350288-77-5 |
C19H18ClN3O5S |
 |
2-(4-carboxypiperidin-1-yl)-3-chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)pyridine 1-oxide |
|
|
 |
Montelukast Impurity H |
851755-56-1 |
C34H32ClNO4S |
 |
Oseltamivir Impurity 92 |
|
|
 |
Oxacillin Sodium Impurity D(EP) |
1642559-63-4 |
C18H21N3O4S |
 |
Anastrozole Impurity 19 |
1301724-97-9 |
C19H21N3O2 |
 |
Terbutaline Impurity 4 |
52144-92-0 |
C33H35NO3 |
 |
Sofosbuvir Impurity28 |
|
|
 |
ノルプテロシンB グルコシド |
1226785-88-1 |
C19H26O7 |
 |
メトレレプチン(遺伝子組換え) |
186018-45-1 |
|
 |
Empagliflozin Impurity 116 |
|
|
 |
Erlotinib |
938185-06-9 |
C16H11N3O2 |
 |
desisopropylprocaterol |
63483-95-4 |
C13H16N2O3 |
 |
2-(2-メトキシフェノキシ)エタノール |
18181-71-0 |
C9H12O3 |
 |
Tallimustine Impurity 2 |
194483-41-5 |
C34H42Cl2N10O4 |
![2-Pyrazinecarboxamide, N-[(1S)-2-[[(1Z)-3-methyl-1-buten-1-yl]amino]-2-oxo-1-(phenylmethyl)ethyl]-](/CAS/20210305/GIF/2276538-67-9.gif) |
2-Pyrazinecarboxamide, N-[(1S)-2-[[(1Z)-3-methyl-1-buten-1-yl]amino]-2-oxo-1-(phenylmethyl)ethyl]- |
2276538-67-9 |
C19H22N4O2 |
 |
DEXTROMETHORPHAN N-OXIDE |
1177494-18-6 |
C18H25NO2 |
 |
Cefradine impurity 5 |
1379292-16-6 |
C10H17NO2 |
 |
Ipragliflozin Impurity 2 |
|
|
 |
nicorandil trimer 07 |
2365474-06-0 |
C24H27N8O9+ |
 |
Apremilast Impurity 3 |
88687-92-7 |
C16H10N2O8 |
 |
Solifenacin Impurity 4(Solifenacin EP Impurity H) |
732228-02-3 |
C23H26N2O2 |
 |
Ofloxacin/Levofloxacin Impurity A |
|
|
 |
Perindopril IMpurity 4 |
|
|
 |
RocuroniuMbroMide iMpurity B |
|
|
![1-NaphthaleneethanaMine, 7-Methoxy-N-[2-(7-Methoxy-1-naphthalenyl)ethyl]-](/CAS/GIF/1385018-57-4.gif) |
1-NaphthaleneethanaMine, 7-Methoxy-N-[2-(7-Methoxy-1-naphthalenyl)ethyl]- |
1385018-57-4 |
C26H27NO2 |
 |
(4S,4aR,5S,5aR,6R,12aS)-3,5,10,12,12a-pentahydroxy-6-methyl-4-(methyl(nitroso)amino)-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide |
|
|
 |
Brivaracet amoxidation Impurity 1 |
|
|
 |
Iohexol Impurity M |
|
|
 |
Pranoprofen Impurity C |
|
|
 |
Mosapride Citric Amide |
1215825-20-9 |
C27H31ClFN3O9 |
 |
アムロジピン-D4 |
1185246-14-3 |
C20H25ClN2O5 |